Physician profile
Fang Yu
NPI 1639466626
$4,143.17
in general payments reported to CMS, 2019-2025
4 companies · $48.70 in 2025
The $48.70 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,737 · 2023: $2,121 · 2024: $237 · 2025: $48.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,027 · Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,026.50 |
| Food and Beverage | $379.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $3,763.50 | 2022-2023 | |
| Gilead Sciences, INC. | $320.17 | 2023-2025 | |
| Ge Healthcare | $59.50 | 2024 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fang Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.